Paper-Based Devices for Capturing Exosomes and Exosomal Nucleic Acids From Biological Samples
- PMID: 35497368
- PMCID: PMC9039228
- DOI: 10.3389/fbioe.2022.836082
Paper-Based Devices for Capturing Exosomes and Exosomal Nucleic Acids From Biological Samples
Abstract
Exosomes, nanovesicles derived from cells, contain a variety of biomolecules that can be considered biomarkers for disease diagnosis, including microRNAs (miRNAs). Given knowledge and demand, inexpensive, robust, and easy-to-use tools that are compatible with downstream nucleic acid detection should be developed to replace traditional methodologies for point-of-care testing (POCT) applications. This study deploys a paper-based extraction kit for exosome and exosomal miRNA analytical system with some quantifying methods to serve as an easy sample preparation for a possible POCT process. Exosomes concentrated from HCT116 cell cultures were arrested on paper-based immunoaffinity devices, which were produced by immobilizing anti-CD63 antibodies on Whatman filter paper, before being subjected to paper-based silica devices for nucleic acids to be trapped by silica nanoparticles adsorbed onto Whatman filter paper. Concentrations of captured exosomes were quantified by enzyme-linked immunosorbent assay (ELISA), demonstrating that paper-based immunoaffinity devices succeeded in capturing and determining exosome levels from cells cultured in both neutral and acidic microenvironments, whereas microRNA 21 (miR-21), a biomarker for various types of cancers and among the nucleic acids absorbed onto the silica devices, was determined by reverse transcription quantitative polymerase chain reaction (RT-qPCR) to prove that paper-based silica devices were capable of trapping exosomal nucleic acids. The developed paper-based kit and the devised procedure was successfully exploited to isolate exosomes and exosomal nucleic acids from different biological samples (platelet-poor plasma and lesion fluid) as clinical applications.
Keywords: colorimetric sensing; exosomal miRNA; exosome; immunoassay; nucleic acid extraction; paper-based device; plasma; wound fluid.
Copyright © 2022 Lai, Lee, Vu, Vu, Tsai, Chen and Cheng.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures
References
-
- Bautista-Sánchez D., Arriaga-Canon C., Pedroza-Torres A., De La Rosa-Velázquez I. A., González-Barrios R., Contreras-Espinosa L., et al. (2020). The Promising Role of miR-21 as a Cancer Biomarker and its Importance in RNA-Based Therapeutics. Mol. Ther. - Nucleic Acids 20, 409–420. 10.1016/j.omtn.2020.03.003 - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous
